Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-006676

Options or other derivatives

  • Director acquired 68,961 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Andraczke Andrzej · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-21 Grant or award : show line 1 in the form Option to purchase common stock +68,961 74,914 D
Loading xslF345X05/ownership.xml…